To assess the association between cardiovascular health, evaluated using Life's Essential 8, and remaining life expectancy among adults with chronic kidney disease compared with matched individuals without kidney disease.
In the Kailuan Study, 26,510 participants with chronic kidney disease (CKD) were age- and sex-matched to 49,034 individuals without CKD and followed for a median of 15.2 years (IQR, 12.6-17.0).
Cardiovascular health (CVH) was classified via Life's Essential 8 as low (<50), moderate (50-79), or high (≥80), and flexible parametric survival models estimated remaining life expectancy at age 40.
All-cause mortality occurred in 6,265 of 26,510 CKD participants (23.6%) and 7,138 of 49,034 non-CKD individuals (14.6%); remaining life expectancy at age 40 for CKD patients was 38.1 years (95% CI: 37.5-38.8) for low CVH, 41.3 years (95% CI: 40.9-41.7) for moderate CVH, and 44.5 years (95% CI: 43.1-46.0) for high CVH.
High versus low CVH corresponded to a 6.5-year gain (95% CI: 4.3-8.5) in life expectancy in CKD, bringing survival to a level comparable to non-CKD individuals (45.0 years, 95% CI: 44.6-45.3; difference: −0.1 years, 95% CI: −2.1 to 0.9), with approximately 60% of years gained (3.9 of 6.5 years) attributable to fewer cardiovascular deaths.
Ask about this paper
Answers are grounded in this paper and cite their sources.
Implication
Cohort study reveals high cardiovascular health extends life expectancy in chronic kidney disease, indicating that ideal heart health offsets disease-associated survival loss.
Abstract
No abstract yet. The journal hasn't published one we can show.
Discussion
No takes yet. Share an insight, caveat, or question.